Research Article

Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria

Table 1

Baseline characteristics of hospitalised HIV/AIDS patients in relation to antiretroviral therapy status.

Characteristics No HAART Receiving HAART All patients

Age in years-median (IQR)35 (29, 43)40 (34, 48)36 (30, 45)
Minimum–Maximum15–6823–6015–68
Gender (%)
 Male 77 (50.7)32 (58.2) 109 (52.7)
 Female75 (49.3)23 (41.8)98 (47.3)
Marital status (%)
 Ever married 120 (78.9)44 (80.4)164 (79.3)
 Never married32 (21.1)11 (19.6)43 (20.7)
Occupation (%)
 Professionals/Civil servants37 (24.3)14 (25.5)51 (24.6)
 Unemployed housewives52 (34.2)12 (21.8)64 (30.9)
 Artisans 20 (13.2)7 (12.7)27 (13)
 Students 13 (8.6)6 (10.9)19 (9.3)
 Traders/Business11 (7.2)8 (14.5)19 (9.3)
 Farmer 6 (3.9)2 (3.6)8 (3.9)
 Others 13 (8.6)7 (12.7)20 (9.7)
Risk factors for HIV (%)
 Heterosexual 142 (93.4)50 (90.9) 192 (92.8)
 Homosexual 3 (2.0) 2 (36.4) 5 (2.4)
 Multiple sexual partners21 (13.8) 13 (23.6) 34 (16.4)
 Blood transfusion 7 (4.6) 3 (5.5) 10 (4.8)
Symptom duration in days
 Median (IQR)21 (14, 90)60 (14, 90)30 (14, 90)
Hospital stay in days
 Median (IQR)14 (5, 24)14 (7, 30)14 (7, 28)
Packed cell volume
 Median (IQR)27 (20, 33)24 (17, 34)27 (19, 34)
PCV levels (%)
24% 22 (31.9)19 (48.7)41 (38%)
 24–29%20 (29.0)4 (10.3)24 (22.2%)
30%27 (39.1)16 (41.0)43 (39.8%)
Total WBC count
  Median (IQR)5.0 (3.7, 6.5)4.7 (3.9, 6.1)4.9 (3.7, 6.5)
Platelet count-Median (IQR)246 (145, 331)230 (157, 271)233 (142, 310)
CD4 cell count-Median (IQR)136 (5, 201)137 (56, 190)136 (56, 199)
CD4 levels (%)
5011 (23.9)9 (23.7)20 (23.8%)
 50–20023 (50.0)21 (55.2)44 (52.4%)
 201–3507 (15.2)6 (15.8)12 (14.3%)
3515 (10.9)2 (5.3)7 (8.3%)

NB— : number; IQR: interquartile range; WBC: white blood cell; PCV: packed cell volume.
No statistical significant differences were observed in demographic and laboratory variables between HAART experienced and ART naive patients ( , all analyses).